Masimo Corporation (MASI)

NASDAQ: MASI · IEX Real-Time Price · USD
133.44
+0.76 (0.57%)
At close: Mar 18, 2024, 4:00 PM
132.86
-0.58 (-0.43%)
After-hours: Mar 18, 2024, 5:45 PM EDT

Company Description

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide.

The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.

It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions.

In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com.

Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Masimo Corporation
Masimo logo
Country United States
Founded 1989
IPO Date Aug 8, 2007
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 3,800
CEO Joseph E. Kiani

Contact Details

Address:
52 Discovery
Irvine, California 92618
United States
Phone 949-297-7000
Website masimo.com

Stock Details

Ticker Symbol MASI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000937556
CUSIP Number 574795100
ISIN Number US5747951003
Employer ID 33-0368882
SIC Code 3845

Key Executives

Name Position
Joseph E. Kiani Founder, Chief Executive Officer and Chairman
Micah Young Executive Vice President and Chief Financial Officer
Bilal Muhsin Chief Operating Officer
Thomas Samuel McClenahan Executive Vice President, General Counsel and Corporate Secretary
Tao Leopold Levy Executive Vice President of Business Development
Paul Hataishi Senior Vice President and Chief Accounting Officer
Yongsam Lee Executive Vice President and Chief Information Officer
Dr. Steven J. Barker Chairman of Scientific Advisory Board and Chief Science Officer
Eli Kammerman Vice President of Business Development and Investor Relations
Jon Coleman President of Worldwide Sales, Professional Services and Medical Affairs

Latest SEC Filings

Date Type Title
Feb 28, 2024 10-K Annual Report
Feb 27, 2024 8-K Current Report
Feb 15, 2024 8-K Current Report
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 9, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 24, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 16, 2024 8-K Current Report
Jan 10, 2024 8-K Current Report
Nov 22, 2023 8-K Current Report